Literature DB >> 18432379

Beverage preference and risk of alcohol-use disorders: a Danish prospective cohort study.

Trine Flensborg-Madsen1, Joachim Knop, Erik Lykke Mortensen, Ulrik Becker, Nita Makhija, Leo Sher, Morten Grønbaek.   

Abstract

OBJECTIVE: The purpose of this study was to examine whether preferred type of alcoholic beverage influences the later risk of alcohol-use disorders (AUD).
METHOD: A prospective cohort study was used, comprising three updated measures of alcohol intake and covariates, and 26 years of follow-up data on 18,146 individuals from the Copenhagen City Heart Study, Denmark. The study population was linked to three different registers to detect AUD registrations.
RESULTS: For both genders, wine drinking was associated with lower risk of AUD irrespective of the weekly amount of alcohol consumed. Women drinking 15-21 drinks per week of only beer and distilled spirits had a risk of 15.8 (95% confidence interval [CI]: 7.8-33.3) for AUD, whereas those whose total alcohol intake comprised more than 35% wine had a risk of 2.0 (CI: 0.7-5.2). Men drinking 15-21 drinks per week of only beer and distilled spirits had a risk of 3.1 (CI: 1.8-5.4), whereas those whose total alcohol intake comprised more than 35% wine had a risk of 0.8 (CI: 0.3-2.1). Consuming more than 35% beer increased the risk of AUD for women, whereas the percentage of distilled spirits intake did not influence the risk of AUD for either women or men.
CONCLUSIONS: Individuals who include wine when they drink alcohol have lower risks of AUD, independent of the total amount of alcohol consumed. The most likely explanation of these results is that lifestyle factors and personal characteristics are associated with beverage preference.

Entities:  

Mesh:

Year:  2008        PMID: 18432379     DOI: 10.15288/jsad.2008.69.371

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  6 in total

1.  Effects of beverage-specific alcohol consumption on drinking behaviors among urban youth.

Authors:  Mildred M Maldonado-Molina; Jennifer M Reingle; Amy L Tobler; Kelli A Komro
Journal:  J Drug Educ       Date:  2010

2.  Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood.

Authors:  Javier Calleja-Conde; Victor Echeverry-Alzate; Elena Giné; Kora-Mareen Bühler; Roser Nadal; Rafael Maldonado; Fernando Rodríguez de Fonseca; Antoni Gual; Jose Antonio López-Moreno
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

3.  Regulatory Policies for Alcohol, other Psychoactive Substances and Addictive Behaviours: The Role of Level of Use and Potency. A Systematic Review.

Authors:  Jürgen Rehm; Jean-François Crépault; Omer S M Hasan; Dirk W Lachenmeier; Robin Room; Bundit Sornpaisarn
Journal:  Int J Environ Res Public Health       Date:  2019-10-04       Impact factor: 3.390

4.  Alcohol use disorders, beverage preferences and the influence of alcohol marketing: a preliminary study.

Authors:  Morgane Guillou Landreat; Céline Beauvais; Marie Grall Bronnec; Delphine Le Goff; Jean Yves Le Reste; Delphine Lever; Antoine Dany; Karine Gallopel Morvan
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-11-30

5.  Does the Combination Matter? Examining the Influence of Alcohol and Cannabis Product Combinations on Simultaneous Use and Consequences in Daily Life.

Authors:  Angela K Stevens; Elizabeth R Aston; Rachel L Gunn; Alexander W Sokolovsky; Hayley Treloar Padovano; Helene R White; Kristina M Jackson
Journal:  Alcohol Clin Exp Res       Date:  2020-11-26       Impact factor: 3.928

6.  A daily glass of red wine associated with lifestyle changes independently improves blood lipids in patients with carotid arteriosclerosis: results from a randomized controlled trial.

Authors:  Dirk W Droste; Catalina Iliescu; Michel Vaillant; Manon Gantenbein; Nancy De Bremaeker; Charlotte Lieunard; Telma Velez; Michèle Meyer; Tessy Guth; Andrea Kuemmerle; Georges Gilson; Anna Chioti
Journal:  Nutr J       Date:  2013-11-15       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.